CBL0137 in Treating Patients With Advanced Extremity Melanoma or Sarcoma

NCT03727789 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped low accrual

Conditions

Advanced Cutaneous Melanoma of the Extremity
Advanced Sarcoma of the Extremity
Clinical Stage III Cutaneous Melanoma AJCC v8
Clinical Stage IV Cutaneous Melanoma AJCC v8
Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
Pathologic Stage IIIC Cutaneous Melanoma AJCC v8
Pathologic Stage IV Cutaneous Melanoma AJCC v8
Recurrent Cutaneous Melanoma of the Extremity
Recurrent Sarcoma of the Extremity
Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8

Interventions

DRUG: FACT Complex-targeting Curaxin CBL0137

Sponsor

Roswell Park Cancer Institute

Collaborators

[object Object]